Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for CERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 1997. Start Trial.
Date Value
July 31, 2026 86.45%
June 30, 2026 86.45%
May 31, 2026 86.45%
April 30, 2026 86.45%
March 31, 2026 86.45%
February 28, 2026 86.45%
January 31, 2026 86.45%
December 31, 2025 86.45%
November 30, 2025 86.45%
October 31, 2025 86.45%
September 30, 2025 86.45%
August 31, 2025 86.45%
July 31, 2025 85.75%
June 30, 2025 85.75%
May 31, 2025 85.75%
April 30, 2025 85.75%
March 31, 2025 85.40%
February 28, 2025 85.40%
January 31, 2025 85.40%
December 31, 2024 85.40%
November 30, 2024 85.40%
October 31, 2024 85.40%
September 30, 2024 85.40%
August 31, 2024 85.40%
July 31, 2024 85.40%
Date Value
June 30, 2024 85.40%
May 31, 2024 85.40%
April 30, 2024 85.40%
March 31, 2024 85.40%
February 29, 2024 85.40%
January 31, 2024 85.40%
December 31, 2023 85.40%
November 30, 2023 85.40%
October 31, 2023 85.40%
September 30, 2023 82.48%
August 31, 2023 80.26%
July 31, 2023 79.09%
June 30, 2023 79.09%
May 31, 2023 79.09%
April 30, 2023 73.25%
March 31, 2023 69.04%
February 28, 2023 68.22%
January 31, 2023 68.22%
December 31, 2022 63.11%
November 30, 2022 63.11%
October 31, 2022 63.77%
September 30, 2022 65.28%
August 31, 2022 68.80%
July 31, 2022 72.08%
June 30, 2022 72.96%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
DexCom, Inc. 66.32%
Abbott Laboratories 39.63%
AngioDynamics, Inc. 82.98%
Alphatec Holdings, Inc. 73.51%
AtriCure, Inc. 77.21%